Fig. 1From: Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failureCorrelations between ANP, NT-proBNP, exenatide concentrations and hemodynamic parameters after 6 h of exenatide infusionBack to article page